Fox Christine
EVP, U.S. Commercial
Fox Christine has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: May 4, 2026.
On the most recent filing, Fox Christine is listed as EVP, U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD. Inside the rolling window, Fox Christine reported no open-market purchases and 5 open-market sales totaling $2.7M in TEVA. The largest disclosed transaction in the window is a sale of 30,000 TEVA shares on Nov 14, 2025, worth $753K.
Companies traded
Other insiders at TEVA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Fox Christine made?
Fox Christine has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Fox Christine trade?
Fox Christine has filed SEC Form 4 disclosures for 1 company, including TEVA.
When was Fox Christine's most recent SEC Form 4 filing?
Fox Christine's most recent SEC Form 4 filing on Tracefour is dated May 4, 2026.
What is Fox Christine's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Fox Christine is listed as EVP, U.S. Commercial.
What is Fox Christine's total buy and sell value in the current window?
Inside the rolling retention window, Fox Christine bought $0 and sold $2.7M based on SEC Form 4 filings.
What was Fox Christine's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,000 TEVA shares on 2025-11-14, worth $753K, per SEC Form 4 filings.